Dysport regulatory update

Ipsen said Health Canada approved Dysport abobotulinumtoxinA to treat glabellar lines. Valeant's Medicis Aesthetics Canada division is expected

Read the full 180 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE